A joint study between Amsterdam University Medical Centers and MEDLAB analyzed over two dozen glucose sensors, insulin pumps, and insulin infusion sets to identify the chemicals present in these ...

AdvaMed has welcomed adjustments to the CMS’s competitive bidding programme yet remains concerned over patient access issues.

CMS late on Friday afternoon released the 2026 Home Health Prospective Payment System Final Rule with final details for the next round of its national competitive bidding program (CBP), ...

A Type 1 diabetic who recently moved to Nova Scotia said they paid hundreds of dollars out of pocket while trying to apply ...

Children using advanced hybrid closed-loop insulin pumps achieved better glucose control, yet most failed to follow dietary and exercise guidelines, highlighting that technology alone cannot replace ...

Researchers at the Indiana University School of Medicine have discovered a new way to regulate blood glucose levels using a lab-designed protein, possibly opening the door to a new treatment avenue ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ ...

[Image from Modular Medical on LinkedIn] Modular Medical (Nasdaq:MODD) announced that it received Institutional Review Board (IRB) approval to study its next-generation insulin pump. San Diego-based ...

Gaps in access to prescribed diabetes technology are common, often arise from early device failure, and lead to disruptions in diabetes management, new research found. The top three reasons for the ...